Outbreak Risk Expands to Dozens of TN Facilities

The FDA has now expanded the fungal meningitis risk to patients who have had eye and heart surgeries since May 21. Image courtesy Food and Drug Administration

As many as 75 medical facilities in Tennessee may have used contaminated drugs from a compounding pharmacy in Massachusetts. The Food and Drug Administration has now expanded the risk to injectable drugs used in eye and heart surgeries.

So far, the 59 fungal meningitis cases in the state are linked to epidural steroid injections at three pain clinics, which include an outpatient facility at St. Thomas Hospital.

The Tennessee Department of Health is not yet naming names of new facilities but says as many as 75 may have received tainted drugs from the New England Compounding Center. The FDA has issued an alert so doctors can warn patients. The time period of concern for those who’ve had eye and heart surgeries runs from May 21st to October 4th.

Please keep your community civil. Comments will be moderated prior to posting, and Nashville Public Radio reserves the right to approve them at its discretion. Comments containing links promoting goods, services - even noble organizations - will not be published. Your comments may include external links, but all comments with links will be delayed as they are reviewed. Comments containing profanity will be rejected.